Antimicrobial evaluation of trisubstituted 2-piperazinyl thiazoles
ACTA Pharmaceutica Sciencia · 2019
DOI: 10.23893/1307-2080.aps.05707 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACTA Pharmaceutica Sciencia, 2019. Verfasst von Betül Giray und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Bacterial resistance to the treatment of infectious diseases is the main problem. Many classes of antibiotics are facing resistance and have initiated new efforts to develop new derivatives and discover new chemical classes.1 Gram positive and gram-negative bacteria such as Escherichia coli, Staphylococcus aureus, Micrococcus luteus, Bacillus subtilis, Bacillus cereus, Pseudomonas aeruginosa etc. are responsible for many diverse infections which even can cause of death.2
Zitieren
APA
Giray, B., Yurttaş, L., Şahin, Z., Berk, B., & Demirayak, Ş. (2019). Antimicrobial evaluation of trisubstituted 2-piperazinyl thiazoles. ACTA Pharmaceutica Sciencia. https://doi.org/10.23893/1307-2080.aps.05707
Vancouver
Giray B, Yurttaş L, Şahin Z, Berk B, Demirayak Ş. Antimicrobial evaluation of trisubstituted 2-piperazinyl thiazoles. ACTA Pharmaceutica Sciencia. 2019. doi:10.23893/1307-2080.aps.05707
BibTeX
@article{Giray2019,
author = {Giray, Betül and Yurttaş, Leyla and Şahin, Zafer and Berk, Barkın and Demirayak, Şeref},
title = {Antimicrobial evaluation of trisubstituted 2-piperazinyl thiazoles},
journal = {ACTA Pharmaceutica Sciencia},
year = {2019},
doi = {10.23893/1307-2080.aps.05707}
}
EUVIMED